Search for a command to run...
In diabetic patients, haematological alterations are associated with the production of reactive oxygen species (ROS) as a consequence of long-term hyperglycemia. This chapter examines the beneficial effects of biophotonic therapy on hematologic parameters, with particular emphasis on its relevance to diabetes management. Sunlight, a primary natural source of photonic energy, has historically been associated with healing processes, including relief from infections, support of wound repair, and enhancement of general vitality. Although the molecular mechanisms underlying photon-mediated therapies remain incompletely defined, emerging evidence suggests that UV-derived light can modulate immune responses, inhibit microbial replication, and improve peripheral tissue oxygenation. The complex immunologic effects of UV exposure include both vitamin D–mediated immune support and, in excessive doses, immunosuppressive changes accompanied by DNA damage. Notably, biophotonic interventions have been linked to reductions in HbA1c concentrations, representing a potentially significant advance in diabetic care. These effects may stem from the photodissociation of oxygen from oxyhemoglobin, resulting in enhanced oxygen availability and improved tissue regeneration. Collectively, the chapter highlights the therapeutic promise of biophotonic approaches as adjunctive strategies for improving hematologic function and metabolic outcomes in individuals with diabetes.